The public health and the question of the "best vaccine"
- PMID: 35644671
- PMCID: PMC9133921
- DOI: 10.1016/j.vaccine.2022.05.044
The public health and the question of the "best vaccine"
Keywords: Cost-effectiveness; Head-to-head studies; Herpes Zoster vaccines; Vaccine hesitancy.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Long-term efficacy data for the recombinant zoster vaccine: impact on public health and cost effectiveness in Germany.Hum Vaccin Immunother. 2021 Dec 2;17(12):5296-5303. doi: 10.1080/21645515.2021.2002085. Epub 2021 Dec 14. Hum Vaccin Immunother. 2021. PMID: 34905463 Free PMC article.
-
Effectiveness and cost-effectiveness of vaccination against herpes zoster in Canada: a modelling study.CMAJ. 2019 Aug 26;191(34):E932-E939. doi: 10.1503/cmaj.190274. CMAJ. 2019. PMID: 31451524 Free PMC article.
-
Avoiding rash decisions about zoster vaccination: insights from cost-effectiveness evidence.BMC Med. 2018 Dec 18;16(1):238. doi: 10.1186/s12916-018-1231-3. BMC Med. 2018. PMID: 30558674 Free PMC article.
-
Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review.Pharmacoeconomics. 2019 Feb;37(2):169-200. doi: 10.1007/s40273-018-0735-1. Pharmacoeconomics. 2019. PMID: 30367401
-
Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults.Drugs Aging. 2010 Feb 1;27(2):159-76. doi: 10.2165/10489140-000000000-00000. Drugs Aging. 2010. PMID: 20104941 Review.
Cited by
-
Efficacy and effectiveness of Herpes zoster vaccination in adults with diabetes mellitus: a systematic review and meta-analysis of clinical trials and observational studies.Acta Diabetol. 2023 Oct;60(10):1343-1349. doi: 10.1007/s00592-023-02127-7. Epub 2023 Jun 20. Acta Diabetol. 2023. PMID: 37340183 Free PMC article.
-
Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression.Vaccines (Basel). 2024 May 11;12(5):527. doi: 10.3390/vaccines12050527. Vaccines (Basel). 2024. PMID: 38793778 Free PMC article. Review.
References
-
- Alderson J, Batchelor V, O'Hanlon M, Cifuentes L, Richter FC, Kopycinski J; Oxford-Cardiff COVID-19 Literature Consortium. Overview of approved and upcoming vaccines for SARS-CoV-2: a living review. Oxf Open Immunol. 2021 May 22;2(1):iqab010. doi: 10.1093/oxfimm/iqab010. PMID: 34522886; PMCID: PMC8194545. - PMC - PubMed
-
- Italian Ministry of Health. Note n. 26246 of 2021, 11 June. Update of Scientific Technical Committee on the vaccine. Available on line at https://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2021&co..., accessed on 2021, 11 October.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical